Gen Digital Inc. (GEN)
NASDAQ: GEN · Real-Time Price · USD
29.06
+0.15 (0.52%)
At close: May 12, 2025, 4:00 PM
28.96
-0.10 (-0.34%)
After-hours: May 12, 2025, 4:07 PM EDT

Company Description

Gen Digital Inc. engages in the provision of cyber safety solutions for consumers.

The company offers security and performance, identity protection, and online privacy, as well as technology platform.

It offers its products under Norton, Avast, Avira, AVG, and CCleaner brands. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022.

Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Gen Digital Inc.
Gen Digital logo
Country United States
Founded 1982
Industry Software - Infrastructure
Sector Technology
Employees 3,400
CEO Vincent Pilette

Contact Details

Address:
60 East Rio Salado Parkway, Suite 1000
Tempe, Arizona 85281
United States
Phone 650 527 8000
Website gendigital.com

Stock Details

Ticker Symbol GEN
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000849399
CUSIP Number 668771108
ISIN Number US6687711084
Employer ID 77-0181864
SIC Code 7372

Key Executives

Name Position
Vincent Pilette Chief Executive Officer, President and Director
Natalie Marie Derse Chief Financial Officer
Bryan Seuk Ko J.D. Chief Legal Officer, Secretary and Head of Corporate Development
Jason Starr Head of Investor Relation
Spring Harris Head of Global Corporate Communications and PR
Kara Jordan Chief Human Resources Officer
Patrick Schwind Head of Customer Experience

Latest SEC Filings

Date Type Title
May 6, 2025 8-K Current Report
May 2, 2025 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 17, 2025 SCHEDULE 13G/A Filing
Apr 17, 2025 8-K Current Report
Apr 17, 2025 S-8 Securities to be offered to employees in employee benefit plans
Apr 16, 2025 CERT Certification by an exchange approving securities for listing
Apr 16, 2025 8-A12B Registration of securities
Mar 5, 2025 EFFECT Notice of Effectiveness
Mar 5, 2025 424B3 Prospectus
Mar 4, 2025 S-4/A Filing